AJCC Staging Moments AJCC TNM Staging 7th Edition Colon Case #2 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.

Slides:



Advertisements
Similar presentations
TNM staging and prognosis Alexandru Eniu, MD, PhD Medical Oncologist Department of Breast Tumors Cancer Institute Ion Chiricuţă Cluj-Napoca, Romania.
Advertisements

AJCC Staging Moments AJCC TNM Staging 7th Edition Rectal Case #3 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.
AJCC TNM Staging 7th Edition Thyroid Case #3
AJCC TNM Staging 7th Edition Colon Case #1
AJCC Staging Moments AJCC TNM Staging 7th Edition Melanoma Case #1 Contributors: Jeffrey E. Gershenwald, MD University of Texas MD Anderson Cancer Center,
AJCC Staging Moments AJCC TNM Staging 7th Edition Glottic Larynx Case #1 Contributors: Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New York,
Matthew Kilmurry, M.D. St. Mary’s General Hospital Grand River Hospital.
62 years old man Main complaint: Back pain at night but not during the day Loss of appettite Weight loss.
Breast cancer and medical second opinion
Statistics and Medicine – Friends or Foes? Monika Krzyzanowska MD MPH Medical Oncologist, Princess Margaret Cancer Centre Associate Professor of Medicine,
Tumors of the bile ducts
AJCC TNM Staging 7th Edition Breast Case #3
Colorectal cancer Khayal AlKhayal MD,FRCSC
AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #3 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.
Treatment of Early Malignant Rectal Polyp
Ductal Carcinoma in situ
Bowel Cancer Alex Hill. Why screen for bowel cancer?  Bowel cancer causes deaths per yr  It may be detected at asymptomatic stage by simple, safe.
AJCC TNM Staging 7th Edition Melanoma Case #2
AJCC Staging Moments AJCC TNM Staging 7th Edition Melanoma Case #3 Contributors: Jeffrey E. Gershenwald, MD University of Texas MD Anderson Cancer Center,
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #2 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
AJCC Staging Moments AJCC TNM Staging 7th Edition Lung Case #1 Contributors: Valerie W. Rusch, MD Memorial Sloan-Kettering Cancer Center, New York, New.
Colon Cancer Daniel A. Nikcevich, MD, PhD Duluth Clinic Cancer Center January 26, 2009.
© Copyright 2003 Cardinal Health, Inc. or one of its subsidiaries. All rights reserved. PET in Colorectal Cancer Early detection of disease Precise Staging.
AJCC Staging Moments AJCC TNM Staging 7th Edition Breast Case #1 Contributors: Stephen B. Edge, MD Roswell Park Cancer Institute, Buffalo, New York David.
SYB Case 2 By: Amy. History 63 y/o female History of left breast infiltrating duct carcinoma s/p mastectomy in 1996 and chemotherapy ER negative, PR negative,
 Determining the Nature of a Breast Abnormality  It is a procedure that may be used to determine whether a lump is a cyst (sac containing fluid) or a.
Slides last updated: March 2015 CRC: STAGING. How colorectal cancer (CRC) is staged 1 Stage describes the extent of cancer, and is one of the most important.
Putting the Puzzle Together: Breast Collaborative Staging Melissa Riddle, RHIT, CTR October 6, 2012.
PANCREATIC CANCER.
AJCC Staging Moments AJCC TNM Staging 7th Edition Supraglottic Larynx Case #2 Contributors: Jatin P. Shah, MD Memorial Sloan-Kettering Cancer Center, New.
COLON CANCER A MAJOR ISSUE IN ALASKA. A common malignancy 200,000 cases in the U. S. in ,000 cases in the U. S. in 2008 Greater than 50 new cases.
AJCC 6 TH EDITION STAGING OF BREAST CARCINOMA. AJCC NODE STAGING -16 CATEGORIES pNX – 1 option pN0 – 5 options; null,(i-),(i+),(mol-),(mol+) pN1 – 4.
Targeting HER2 and Focusing on Patients With Gastric Cancer Jose Maria Vieitez, MD, PhD Assistant Professor of Oncology Department of Medical Oncology.
NSCLC stage IIIA type of chemotherapy ? Swiss tumor board Bern – Dr. Christian Monnerat Département Pluridisciplaire d’Oncologie – Hôpital Neuchâtelois.
A 58 years old man presents with melena. What would you ask him?
Colon Cancer. Multihit Concept Clinical Information Clinical Information 1. Patient identification a. Name b. Identification number c. Age (birth date)
The “Hand” of Appendix Cancer Presented to American Association of Primary Care Endoscopy Brian W. Meeker, D.O. Vinton, Ia. 53 y/o male presents for “screening”
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of colorectal cancer: case report and literature review Alexandra.
The role of Endoscopy in Gastric Cancer Fergal Donnellan Gastroenterologist VGH.
TNM Staging: Prostate TONYA BRANDENBURG, MHA, CTR KENTUCKY CANCER REGISTRY.
TNM Staging: Colon and Rectum
Tonya Brandenburg, MHA, CTR Kentucky Cancer Registry
Nicole Catlett, CTR KCR Abstractor’s Training April 21-23,
ajcc TNM Staging: chapter 1, and Summary stage
Collaborative Staging for Colon Site Specific Factors Tonya Brandenburg, MHA, CTR QA Manager Abstracting and Coding Kentucky Cancer Registry.
LLG03999 TN Categorization for Rectal and Colon Cancers Based on National Survival Outcome Data 1 Mayo Clinic Cancer Center – Arizona; Scottsdale, AZ 2.
Anaplastic thyroid cancer based on ATA guideline for Management of Patients with ATC. Thyroid. 2012;22: R3 이정록.
KCR Spring Training T,N,M Case Examples Tonya Brandenburg.
Case 1. Diagnosis : Stomach, resection margin, proximal, FS-1, biopsy: No tumor Stomach, resection margin, distal, FS-2, biopsy: Adenocarcinoma Lymph.
The Malignant Polyp Handout Version Hans Elzinga, MD Program Director- Advanced Procedures in Family Medicine Fellowship Salud Family Health Center-Longmont,
Case. Kreem is 53 year old man who is quite healthy with no previous illness. He has noticed changes in his bowel habits for the last few months, with.
Risk Stratification in Stage II Colon Cancer Patients Ramzi Amri, MD, PhD; Liliana G Bordeianou, MD, MPH; and David L Berger, MD Massachusetts General.
THE IMPORTANCE OF STAGING AND PROGNOSTIC FACTORS IN CANCER CARE
RECURRENT METASTATIC LARGE CELL NEUROENDOCRINE CARCINOMA OF CAECUM
The IASLC Lung Cancer Staging Project The 8th Edition
Underwriting Breast Cancer
Department of General Surgery, Upper Gastrointestinal Unit,
Dr.Amit Gupta Associate Professor Dept. of Surgery
LL Gunderson1, JM Jessup 2, DJ Sargent 3, FL Greene 4, A Stewart 5
Neuro-Endocrine Tumoren De Appendix in het Bijzonder
Dr Amit Gupta Associate Professor Dept of Surgery
Improved survival outcomes after resection of ductal adenocarcinoma in the body and tail of the pancreas: A single center 10 years’ experience Seong.
What’s New for 8th Edition
Cancer Staging.
Dr T P E Wells 13 July 2018 Breast SSG Bath
Colon Cancer Stages I-III
Treatment Overview: The Multidisciplinary Team
The Nuances of Staging Lung cancer Gerard A
Changes in TNM 8 To be used from
NSCLC: Staging and TNM classification
Presentation transcript:

AJCC Staging Moments AJCC TNM Staging 7th Edition Colon Case #2 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland Mary Kay Washington, MD Vanderbilt University Medical Center, Nashville, Tennessee Jose Guillem, MD Memorial Sloan-Kettering Cancer Center, New York, New York Frederick L. Greene, MD Carolinas Medical Center, Charlotte, North Carolina

Colon Case # 2 Presentation of New Case Newly diagnosed colon cancer patient Presentation at Cancer Conference for treatment recommendations and clinical staging

Colon Case # 2 History & Physical 55 yr old female who presented with possible appendicitis No family history of any cancer

Colon Case # 2 Imaging & Endoscopy Results CT abd/pelvis-prominent pericecal nodes not diagnostic Colonoscopy-large circumferential mass in cecum used with permission Julio Murra-Saca, MD El Savador Atlas of Gastrointestinal Video Endoscopy

Colon Case # 2 Diagnostic Procedure Procedure –Colonoscopy & biopsy Pathology Report –Adenocarcinoma, invasive –Grade 2 Pre-op CEA was 1.7

Colon Case # 2 Clinical Staging Clinical staging –Uses information from the physical exam, imaging, and diagnostic biopsy Purpose –Select appropriate treatment –Estimate prognosis

Colon Case # 2 Clinical Staging Synopsis- patient with large cecal mass, clinically negative nodes What is the clinical stage? –T____ –N____ –M____ –Stage Group______

Colon Case # 2 Clinical Staging Clinical Stage correct answer –TX –N0 –M0 –Stage Group unknown Based on stage, treatment is selected Review NCCN treatment guidelines for this stage

Colon Case # 2 Clinical Staging Rationale for staging choices –TX for cannot be assessed –N0 because nodes were clinically negative on imaging –M0 because there was nothing to suggest distant metastases; if there was, appropriate tests would be performed before developing a treatment plan

Prognostic Factors Clinically Significant Applicable to this case –CEA: 1.7 There are no prognostic factors required for staging

Colon Case # 2 Presentation after Surgery The procedure chosen based on the large cecal mass with no nodes or distant spread, Stage unknown, is resection Presentation at Cancer Conference for treatment recommendations and pathologic staging

Colon Case # 2 Surgery & Findings Procedure –Right hemicolectomy Pre-op CEA was 1.7 Operative findings –Mobile cecum without retroperitoneal invasion –No palpable liver metastases

Colon Case # 2 Pathology Results Adenocarcinoma, cecum Size of tumor - 4.2cm Grade 2 Penetrates through wall into mesentery with perforation and perforates visceral peritoneum Margins negative Circumferential resection margin was clear by 3mm 12 mesenteric nodes negative There was no perineural or lymph-vascular invasion Tumor deposits were not identified

Colon Case # 2 Pathologic Staging Pathologic staging –Uses information from the clinical staging supplemented or modified by information from surgery and the pathology report Purpose –Additional precise data for estimating prognosis –Calculating end results (survival data)

Colon Case # 2 Pathologic Staging Synopsis- patient with 4.2cm cecal mass perforating mesentery and visceral peritoneum, nodes negative What is the pathologic stage? (remember, clinical M may be used in pathologic staging) –T____ –N____ –M____ –Stage Group______

Colon Case # 2 Pathologic Staging Pathologic Stage correct answer –pT4a –pN0 –cM0 –Stage Group IIB Based on pathologic stage, there is more information to estimate prognosis and adjuvant treatment is discussed

Colon Case # 2 Pathologic Staging Rationale for staging choices –pT4a is penetrates to surface of visceral peritoneum –pN0 because mesenteric nodes were negative –cM0 - use clinical M with pathologic staging unless there is pathologic confirmation of distant metastases

Prognostic Factors Clinically Significant Applicable to this case –CEA: 1.7 –Circumferential resection margin: 3mm –Tumor deposits: no –Perineural invasion: no There are no prognostic factors required for staging

AJCC Cancer Staging Atlas T4 directly invades other organs or structures, and/or perforates visceral peritoneum

Colon Case # 2 Recap of Staging Summary of correct answers –Clinical stage TX N0 M0 Stage Group unknown –Pathologic stage T4a N0 cM0 Stage Group IIB The staging classifications have a different purpose and therefore can be different. Do not go back and change the clinical staging based on pathologic staging information.

Staging Moments Summary Review site-specific information if needed Clinical Staging –Based on information before treatment –Used to select treatment options Pathologic Staging –Based on clinical data PLUS surgery and pathology report information –Used to evaluate end-results (survival)